{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:06Z","timestamp":1767134766424,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003778","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,4,20]],"date-time":"2005-04-20T00:00:00Z","timestamp":1113955200000}}],"reference-count":86,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003778.pub2","type":"journal-article","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T10:35:41Z","timestamp":1114166141000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glucocorticosteroids for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Martin","family":"Prince","sequence":"first","affiliation":[{"name":"Manchester Royal Infirmary; Oxford Road Manchester UK M13 9WL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Christensen","sequence":"additional","affiliation":[{"name":"Bispebjerg Hospital; Clinic of Internal Medicine I; Bispebjerg Bakke 23 Copenhagen NV Denmark DK-2400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD003778.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003778.pub2-BIB0002|cit2","first-page":"471A","article-title":"Ursodeoxycholic acid (UDCA) and budesonide (BUD) in the treatment of primary biliary cirrhosis (PBC). A prospective double-blind trial","volume":"30","author":"Leuschner","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD003778.pub2-BIB0003|cit3","first-page":"GS4\/20","article-title":"Ursodeoxycholic acid (UDCA) and budesonide (BUD) is superior to UDCA monotherapy in primary biliary cirrhosis (PBC)","volume":"30","author":"Leuschner","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0004|cit4","unstructured":"Leuschner U Maier KP Guldutuna S Parte-Peterhans S Leuschner M Ursodeoxycholic acid in combination with prednisolone or budenoside in therapy of primary biliary cirrhosis Falk Symposium 93 Dodecht Kluwer 1997 299 302"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0005|cit5","unstructured":"Leuscner U Maier P Schitling J Strahl R Herrmann G Leuschner M Ursodeoxycholic acid and budenoside in the treatment of primary biliary cirrhosis XV International Bile Acid Meeting Bile Acids and Cholestasis 1998 60 1"},{"issue":"4","key":"10.1002\/14651858.CD003778.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.1840100418","article-title":"Prednisolone for primary biliary cirrhosis - good news, bad news","volume":"10","author":"Combes","year":"1989","journal-title":"Hepatology"},{"issue":"Supp 1","key":"10.1002\/14651858.CD003778.pub2-BIB0007|cit7","first-page":"S28","article-title":"A pilot double blind controlled trial of prednisolone treatment in primary biliary cirrhosis (PBC) [EASL abstract]","volume":"3","author":"Mitchison","year":"1986","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD003778.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0168-8278(89)90096-2","article-title":"Double blind placebo-controlled trial of prednisolone treatment in primary biliary cirrhosis (PBC): a 3 year update [EASL abstract]","volume":"9","author":"Mitchison","year":"1989","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD003778.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003778.pub2-BIB0011|cit11","first-page":"340","article-title":"Effect of cyclosporin and cyclosporin and prenisolone in primary biliary cirrhosis","volume":"20","author":"Beukers","year":"1988","journal-title":"Transplant Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003778.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(92)90123-7","article-title":"Immunosuppressive therapy for primary biliary cirrhosis","volume":"14","author":"Beukers","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(55)80027-3","article-title":"Effect of steroid theraapy on the clinical and laboraoty features in primary biliary cirrhosis","volume":"28","author":"Carman","year":"1955","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0014|cit14","first-page":"463","article-title":"Serum interferon gamma in primary bilary cirrhosis: effect of ursodeoxycholic acid and prednisolone therapy alone and in combination","volume":"121","author":"Fracchia","year":"2000","journal-title":"EJGH"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510380301","article-title":"Ursodeoxycholic acid and budesonide for PBC. Unexpected risks and benefits","volume":"38","author":"Elias","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Hempfling W Grunhage F Dilger K Reichel C Beuers U Sauerbrach T Pharmacokinetics and pharmacodynamic action of budesonide in early stage primary biliary cirrhosis Hepatology 2002 422A","DOI":"10.1053\/jhep.2003.50266"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmodynamic action of budesonide in early and late stage PBC","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0018|cit18","first-page":"423A","article-title":"Portal vein thrombosis in patients with late stage primary biliary cirrhosis treated with budesonide","volume":"36","author":"Hempfling","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD003778.pub2-BIB0020|cit19","first-page":"79","article-title":"Ursodeoxycholic acid in combination with prednisolone","volume":"2","author":"Leuschner","year":"1997","journal-title":"Progress in Hepatopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003778.pub2-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0021|cit21","first-page":"299","article-title":"Ursodeoxycholic acid in combination with prednisolone or budenoside in therapy of primary biliary cirrhosis","volume":"1","author":"Leuschner","year":"1997","journal-title":"Falk Symposium 93"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0022|cit22","first-page":"870","article-title":"Observations on the effect of cortisone acetate in two pateints with hepatic disease","volume":"37","author":"Butt","year":"1951","journal-title":"Journal of Laboratory and Clincal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0046-8177(72)80072-8","article-title":"Chronic acitve liver disease. Range of histologic lesions and thier response to treatment and evolution","volume":"3","author":"Baggenstoss","year":"1972","journal-title":"Human Pathology"},{"issue":"5","key":"10.1002\/14651858.CD003778.pub2-BIB0024|cit24","first-page":"932","article-title":"Steroid side effect during therapy of chronic liver disease; what to expect","volume":"71","author":"Uribe","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with a suboptimal response to UDCA","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003778.pub2-BIB0026|cit26","first-page":"471A","article-title":"Budesonide in the treatment of patients with a suboptimal response to UDCA","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003778.pub2-BIB0027|cit27","first-page":"471A","article-title":"Prednisolone treatment changes T-cell reptiore in primary biliary cirrhosis. Clonal analysis of T cell receptor","volume":"30","author":"Okamoto","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0028|cit28","first-page":"228","article-title":"Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy","volume":"23","author":"Taal","year":"1985","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0016-5085(90)90635-E","article-title":"Bone mass in women with primary biliary cirrhosis. The relation with histological stage and use of glucocorticoids","volume":"99","author":"Berkum","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0030|cit30","first-page":"227","article-title":"The late results of long term treatment of primary biliary cirrhosis by corticosteroids","volume":"16","author":"Howat","year":"1966","journal-title":"Revue Internationale d Hepatologie"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000201849","article-title":"The biochemical changes induced by corticosteroids in xanthomatous biliary cirrhosis","volume":"89","author":"Wilson","year":"1958","journal-title":"Gastroenterolgia"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0032|cit32","first-page":"A9","article-title":"Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"43","author":"Wolfhagen","year":"1993","journal-title":"Netherlands Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003778.pub2-BIB0033|cit33","first-page":"84","article-title":"Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"44","author":"Wolfhagen","year":"1994","journal-title":"Netherlands Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0034|cit34","first-page":"155","article-title":"Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy","volume":"9","author":"Lim","year":"1997","journal-title":"EJHG"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Lim AG Wolfhagen FHJ Verma A van Buuren HR Jazrawi RP Levy JH Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid, prenisolone and azathioprine Falk Symposium 86 1995","DOI":"10.1016\/0270-9139(95)94222-X"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0036|cit36","unstructured":"Van Burren H Wolfhagen FHJ Lim AG Verma A Jazrawi RP Northfield TC A randomized placebo-controlled trial with prednisone\/azathioprine in addition to ursodeoxycholic acid in primary biliary cirrhosis Falk Symposium 75 1995"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","article-title":"Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study","volume":"26","author":"Wolfhagen","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD003778.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0168-8278(98)80254-7","article-title":"Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study","volume":"29","author":"Wolfhagen","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/0300-2977(95)97022-H","article-title":"Soluble ICAM-1 in primary biliary cirrhosis (PBC) during combined treatment with ursodeoxycholic acid, prednisone and azathioprine [abstract]","volume":"47","author":"Wolfhagen","year":"1994","journal-title":"Netherlands Journal of Medicine"},{"issue":"Supp 1","key":"10.1002\/14651858.CD003778.pub2-BIB0040|cit40","first-page":"S49","article-title":"A randomized placebo-controlled trial with prednisone\/azathioprine in addition to ursodeoxycholic acid in primary biliary cirrhosis","volume":"21","author":"Wolfhagen","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1016\/0300-2977(95)96973-L","article-title":"Prednisone\/azathioprine treatment in primary biliary cirrhosis (PBC). A randomized, placebo-controlled trial [abstract]","volume":"46","author":"Wolfhagen","year":"1995","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0042|cit42","first-page":"168A","article-title":"Combined bile acid-immunocuppressive therapy for primary biliary cirrhosis. Results of a 1-year multi-centre, placebo controlled trial","volume":"24","author":"Hoogstraten","year":"1996","journal-title":"Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD003778.pub2-BIB0043|cit43","first-page":"A41","article-title":"Combined bile acid-immunosuppresive therapy for primary biliary cirrhosis. Results of a l-year multi centre, placebo controlled trial [abstract]","volume":"8","author":"Hoogstraten","year":"1996","journal-title":"EJGH"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-195012000-00002","article-title":"Primary biliary cihrrosis","volume":"29","author":"Ahrens","year":"1950","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0045|cit45","volume-title":"Cochrane Reviewers' Handbook 4.2.1","author":"Alderson","year":"2004"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0046|cit46","first-page":"299","article-title":"Bone disease in obstructive jaundice","volume":"25","author":"Atkinson","year":"1956","journal-title":"Quarterly Journal of Medicine"},{"issue":"20","key":"10.1002\/14651858.CD003778.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003778.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003778.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.510290618","article-title":"Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"29","author":"Combes","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-065X.1982.tb00431.x","article-title":"Coritcosteroid-mediated immunregulation in man","volume":"65","author":"Cupps","year":"1982","journal-title":"Immunological reviews"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8233","key":"10.1002\/14651858.CD003778.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0168-8278(98)80301-2","article-title":"'Negative trials' are positive!","volume":"28","author":"Gluud","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0058|cit58","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis (Protocol for a Cochrane Review)","author":"Gluud","year":"1999","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003778.pub2-BIB0059|cit59","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis (Cochrane Review)","author":"Gluud","year":"2001","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(01)00061-7","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?","volume":"34","author":"Gluud","year":"2001","journal-title":"Jounal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0061|cit61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004789.pub2","article-title":"Colchicine for primary biliary cirrhosis (Cochrane Review)","author":"Gong","year":"2004","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0064|cit64","volume-title":"Code of Federal Regulations & International Conference on Harmonization Guidelines","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0068|cit68","first-page":"1148","article-title":"Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?","volume":"23","author":"Kilmurry","year":"1996","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD003778.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0070|cit70","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD003778.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1993","journal-title":"Jouranl of Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The consort statement revised recommendations for improving the quality of reports of parallel group controlled trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003778.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in primary biliary cirrhosis revisited","volume":"48","author":"Newton","year":"2001","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2249.1999.00803.x","article-title":"T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)","volume":"116","author":"Palmer","year":"1999","journal-title":"Clinical and Experimental Iimmunology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003778.pub2-BIB0079|cit79","first-page":"171A","article-title":"Symptom development and prognosis of initially asymptomatic PBC","volume":"32","author":"Prince","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM198702193160806","article-title":"Meta-analysis of randomised controlled trials","volume":"19","author":"Sacks","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of American Medical Association"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0082|cit82","first-page":"783","article-title":"Osteoporosis in chronic liver disease","volume":"223","author":"Stellon","year":"1985","journal-title":"Quarterly Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003778.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003778.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD003778.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003778.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T16:36:00Z","timestamp":1735662960000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003778.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003778.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,20]]}}}